Natrixam (Indapamide, Amlodipine Besilate)

Indapamide and Amlodipine Besilate, the active ingredients in Natrixam, are a thiazide‑like diuretic and a calcium‑channel blocker presented as an oral tablet for systemic use. They are indicated for the treatment of hypertension in adult patients.

GNH USA supplies Natrixam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Natrixam combines a thiazide‑like diuretic and a calcium‑channel blocker to manage elevated blood pressure. It is employed in the following clinical situations: - Essential hypertension: lowers systolic and diastolic pressure by reducing fluid volume and causing vasodilation. - Secondary hypertension: assists in blood‑pressure control when hypertension is due to another underlying condition. - Isolated systolic hypertension: provides effective reduction of systolic pressure in older adults.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially after standing. - Headache: mild to moderate pressure sensation. - Peripheral edema: swelling of ankles or feet. - Flushing: transient warmth and redness of the skin. - Fatigue: feeling unusually tired. - Palpitations: awareness of heartbeat.

Serious or Rare Side Effects: - Severe hypotension: markedly low blood pressure requiring medical attention. - Electrolyte imbalance: abnormal potassium or sodium levels. - Renal impairment: reduced kidney function. - Angioedema: swelling of face, lips, or throat. - Hepatic dysfunction: elevated liver enzymes. - Allergic reactions: rash, itching, or anaphylaxis.

Before initiating therapy, consider the following precautions: - Blood pressure monitoring: check regularly to avoid excessive lowering. - Renal function assessment: evaluate kidney status, especially in patients with pre‑existing disease. - Electrolyte surveillance: monitor potassium and sodium levels. - Discontinuation guidance: do not stop abruptly without medical advice. - Hepatic impairment: use with caution in patients with liver disease. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Natrixam may interact with several medicines. Review the following categories: Major Interactions (Avoid): - Lithium: increased risk of lithium toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole): elevated amlodipine concentrations. - NSAIDs: may blunt antihypertensive effect. - Potassium‑sparing diuretics: risk of hyperkalemia. - Other antihypertensives: additive hypotensive effect. Moderate Interactions (Monitor Closely): - Beta‑blockers: enhanced blood‑pressure lowering. - ACE inhibitors or ARBs: potential for renal function changes. - Additional thiazide‑type diuretics: electrolyte disturbances. - Alcohol: increased dizziness and hypotension.